<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Recurrent UTI / pyelonephritis red flags — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Recurrent UTI / pyelonephritis red flags</h1>
        <div class="sub">Evidence summary (key statements + how they fit together) → DGRefHelp first draft (D&amp;G).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑12</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key decision points to build the page around</strong>
                <ul>
                  <li><strong>Don’t miss sepsis / complicated pyelonephritis</strong>: NICE NG111 says <strong>refer to hospital</strong> if acute pyelonephritis has <strong>symptoms/signs of serious illness</strong> (e.g. sepsis), and <strong>consider referral</strong> if dehydrated/unable to keep fluids/meds down, <strong>pregnant</strong>, or higher risk of complications (structural/functional abnormality, diabetes, immunosuppression).</li>
                  <li><strong>Recurrent UTI isn’t just “more antibiotics”</strong>: NICE NG112 recommends <strong>referral / specialist advice</strong> for men (male GU system), <strong>recurrent upper UTI</strong>, recurrent lower UTI where cause is unknown, pregnancy, and suspected cancer (per NG12).</li>
                  <li><strong>Cancer safety-net branch</strong>: NICE NG12 includes <strong>non‑urgent referral</strong> for bladder cancer in people aged <strong>60+</strong> with <strong>recurrent or persistent unexplained UTI</strong> (and separate haematuria triggers).</li>
                </ul>
              </div>

              <h4>1) NICE NG111: acute pyelonephritis (antimicrobial prescribing) — what changes actions</h4>
              <ul>
                <li><strong>Send urine for culture</strong> before antibiotics (midstream sample) for adults (and under‑16s per paeds UTI guideline).</li>
                <li><strong>Safety net / reassess:</strong> symptoms should start improving within <strong>48 hours</strong> of antibiotics; reassess if worsening at any time or not improving by 48h.</li>
                <li><strong>Refer to hospital</strong> if any symptoms/signs suggest a more serious illness/condition (example given: <strong>sepsis</strong>).</li>
                <li><strong>Consider referral / specialist advice</strong> if significantly dehydrated / unable to take oral fluids/medicines, <strong>pregnant</strong>, or higher‑risk for complications (structural/functional abnormality, diabetes, immunosuppression).</li>
              </ul>

              <h4>2) NICE NG112: recurrent UTI (prevention) — who needs specialist input</h4>
              <ul>
                <li>Defines recurrent UTI as including <strong>lower UTI and upper UTI (acute pyelonephritis)</strong>.</li>
                <li><strong>Refer / seek specialist advice</strong> for further investigation and management in:
                  <ul>
                    <li>men (and trans women / non-binary people with a male GU system) ≥16</li>
                    <li><strong>recurrent upper UTI</strong></li>
                    <li>recurrent lower UTI when underlying cause is unknown</li>
                    <li>pregnancy</li>
                    <li>suspected cancer (follow NG12)</li>
                    <li>anyone with gender reassignment surgery with structural alteration of the urethra</li>
                  </ul>
                </li>
              </ul>

              <h4>3) NICE NG12: recurrent unexplained UTI in older adults (bladder cancer trigger)</h4>
              <ul>
                <li><strong>Consider non‑urgent referral</strong> for bladder cancer in people aged <strong>60+</strong> with recurrent or persistent <strong>unexplained</strong> UTI.</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (drafting-site only)</strong>
                <ul>
                  <li>Confirm the D&amp;G acute route for suspected pyelonephritis needing same‑day assessment: <strong>ED</strong> vs <strong>SDEC/ambulatory</strong> vs <strong>on‑call medicine/urology</strong> (and whether direct admission is ever appropriate).</li>
                  <li>Confirm local criteria for <strong>“complicated UTI”</strong> that should be discussed with urology (e.g., known stone disease, urinary retention/obstruction, catheter-associated, post‑urological procedure).</li>
                  <li>Confirm whether primary care should request any baseline tests <strong>before urgent referral</strong> (e.g., U&amp;E/creatinine, CRP, blood cultures) vs leaving all tests to the acute pathway.</li>
                  <li>Confirm preferred SCI Gateway destinations/service names for: <strong>urology</strong> (recurrent UTI in men/structural cause) and <strong>urology suspected cancer</strong> (if using local variants of NG12 criteria).</li>
                </ul>
              </div>

              <div class="small">This evidence summary is written for pathway design: it highlights only decision‑changing points and where local policy choices sit.</div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;Recurrent UTI includes recurrent lower UTI and recurrent upper UTI (acute pyelonephritis).&lt;/li&gt;
  &lt;li&gt;Two things not to miss: &lt;strong&gt;(1) sepsis/complicated pyelonephritis&lt;/strong&gt; and &lt;strong&gt;(2) an underlying cause&lt;/strong&gt; (structural/functional problem, stone/obstruction, cancer red flags).&lt;/li&gt;
  &lt;li&gt;NICE NG111: acute pyelonephritis with serious illness (e.g. sepsis) → &lt;strong&gt;hospital assessment&lt;/strong&gt;; consider referral if dehydrated/unable to take oral fluids/meds, &lt;strong&gt;pregnant&lt;/strong&gt;, or higher risk of complications.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Differentiate lower UTI vs pyelonephritis:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;Lower UTI&lt;/strong&gt;: dysuria, frequency/urgency, suprapubic discomfort; usually no systemic features.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Pyelonephritis&lt;/strong&gt;: fever/rigors, flank/loin pain or CVA tenderness, nausea/vomiting, systemic unwell.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Red flags / same‑day assessment:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;features of sepsis or becoming &lt;em&gt;systemically very unwell&lt;/em&gt;&lt;/li&gt;
      &lt;li&gt;unable to keep down oral fluids/antibiotics (vomiting) or significantly dehydrated&lt;/li&gt;
      &lt;li&gt;pregnancy&lt;/li&gt;
      &lt;li&gt;concern for obstruction/complication: known stone disease, anuria/oliguria, urinary retention, new AKI, single kidney/transplant&lt;/li&gt;
      &lt;li&gt;immunosuppression or significant comorbidity (e.g. diabetes) with systemic symptoms&lt;/li&gt;
      &lt;li&gt;severe uncontrolled pain, diagnostic uncertainty, or failure to improve&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Recurrent UTI pattern:&lt;/strong&gt; check organism history (relapse vs reinfection), triggers (sex/contraception), post‑coital symptoms, vaginal symptoms, and any urinary symptoms between infections.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Tests:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Urine dip may support diagnosis but do &lt;strong&gt;MSU for culture&lt;/strong&gt; before antibiotics in suspected pyelonephritis (NICE NG111).&lt;/li&gt;
      &lt;li&gt;If recurrent UTI: send MSU during symptomatic episodes (ideally before antibiotics) to confirm infection/organism.&lt;/li&gt;
      &lt;li&gt;If unwell / red flags: record observations; consider bloods (FBC, U&amp;amp;E/creatinine ± CRP) if this does not delay urgent referral (local process).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;If suspected pyelonephritis and stable for community treatment:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Send MSU for culture &lt;strong&gt;before&lt;/strong&gt; antibiotics (NICE NG111).&lt;/li&gt;
      &lt;li&gt;Start oral antibiotics per &lt;strong&gt;local antimicrobial guidance&lt;/strong&gt;.&lt;/li&gt;
      &lt;li&gt;Safety‑net: symptoms should start improving within &lt;strong&gt;48 hours&lt;/strong&gt;; seek help sooner if worsening or systemically unwell (NICE NG111).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Recurrent UTI prevention (overview):&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Start with behavioural/self‑care measures; consider vaginal oestrogen in peri/post‑menopause if appropriate (NICE NG112).&lt;/li&gt;
      &lt;li&gt;If needed: targeted single‑dose prophylaxis for identifiable triggers or methenamine hippurate / daily antibiotic prophylaxis per NG112 (often needs shared decision making and sometimes specialist advice).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;p&gt;&lt;strong&gt;Same‑day assessment (ED / acute pathway / SDEC)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Suspected &lt;strong&gt;acute pyelonephritis&lt;/strong&gt; with any red flags:&lt;/li&gt;
  &lt;li&gt;
    &lt;ul&gt;
      &lt;li&gt;symptoms/signs of serious illness (e.g. sepsis) — &lt;strong&gt;refer to hospital&lt;/strong&gt; (NICE NG111)&lt;/li&gt;
      &lt;li&gt;significant dehydration or unable to take oral fluids/medicines (NICE NG111)&lt;/li&gt;
      &lt;li&gt;pregnancy (NICE NG111)&lt;/li&gt;
      &lt;li&gt;higher risk of complications (structural/functional abnormality, diabetes, immunosuppression) with systemic symptoms (NICE NG111)&lt;/li&gt;
      &lt;li&gt;concern for obstruction/AKI/single kidney/transplant&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Route (draft):&lt;/strong&gt; ED / SDEC / acute medical assessment (confirm local route).&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Urology / specialist advice (recurrent UTI workup)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Refer / seek specialist advice&lt;/strong&gt; for recurrent UTI in (NICE NG112):&lt;/li&gt;
  &lt;li&gt;
    &lt;ul&gt;
      &lt;li&gt;men (male GU system) ≥16&lt;/li&gt;
      &lt;li&gt;recurrent &lt;strong&gt;upper&lt;/strong&gt; UTI (pyelonephritis)&lt;/li&gt;
      &lt;li&gt;recurrent lower UTI when the underlying cause is unknown&lt;/li&gt;
      &lt;li&gt;pregnancy&lt;/li&gt;
      &lt;li&gt;after gender reassignment surgery with structural alteration of the urethra&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Include: MSU culture history (organisms/resistance), antibiotic courses, triggers, any imaging, and relevant comorbidities.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Cancer safety‑net branch (older adults)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Age &lt;strong&gt;60+&lt;/strong&gt; with recurrent/persistent &lt;strong&gt;unexplained&lt;/strong&gt; UTI → &lt;strong&gt;consider non‑urgent referral&lt;/strong&gt; for bladder cancer (NICE NG12).&lt;/li&gt;
  &lt;li&gt;If visible haematuria triggers are present, follow the haematuria pathway (separate DGRefHelp page).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;Uncomplicated lower UTI responding to treatment, without red flags or concerning pattern.&lt;/li&gt;
  &lt;li&gt;Recurrent UTI with an established prevention plan and good response (review in primary care; re-refer if pattern changes).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;NICE NG111: Pyelonephritis (acute): antimicrobial prescribing — recommendations (referral criteria; reassess if not improving within 48h; MSU before antibiotics). https://www.nice.org.uk/guidance/ng111/chapter/recommendations (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;NICE NG112: Urinary tract infection (recurrent): antimicrobial prescribing — recommendations (who to refer/seek specialist advice; prevention options incl. vaginal oestrogen and methenamine hippurate). https://www.nice.org.uk/guidance/ng112/chapter/recommendations (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;NICE NG12: Suspected cancer: recognition and referral — urological cancers section (consider non‑urgent referral for bladder cancer in age 60+ with recurrent/persistent unexplained UTI). https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer#urological-cancers (retrieved 2026‑02‑12)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Recurrent UTI / pyelonephritis red flags</h3>

              <h4>Background</h4>
              <ul>
                <li>Recurrent UTI includes recurrent lower UTI and recurrent upper UTI (acute pyelonephritis).</li>
                <li>Two things not to miss: <strong>(1) sepsis/complicated pyelonephritis</strong> and <strong>(2) an underlying cause</strong> (structural/functional problem, stone/obstruction, cancer red flags).</li>
                <li>NICE NG111: acute pyelonephritis with serious illness (e.g. sepsis) → <strong>hospital assessment</strong>; consider referral if dehydrated/unable to take oral fluids/meds, <strong>pregnant</strong>, or higher risk of complications.</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>Differentiate lower UTI vs pyelonephritis:</strong>
                  <ul>
                    <li><strong>Lower UTI:</strong> dysuria, frequency/urgency, suprapubic discomfort; usually no systemic features.</li>
                    <li><strong>Pyelonephritis:</strong> fever/rigors, flank/loin pain or CVA tenderness, nausea/vomiting, systemic unwell.</li>
                  </ul>
                </li>

                <li><strong>Red flags / same‑day assessment:</strong>
                  <ul>
                    <li>features of sepsis or becoming <em>systemically very unwell</em></li>
                    <li>unable to keep down oral fluids/antibiotics (vomiting) or significantly dehydrated</li>
                    <li>pregnancy</li>
                    <li>concern for obstruction/complication: known stone disease, anuria/oliguria, urinary retention, new AKI, single kidney/transplant</li>
                    <li>immunosuppression or significant comorbidity (e.g. diabetes) with systemic symptoms</li>
                    <li>severe uncontrolled pain, diagnostic uncertainty, or failure to improve</li>
                  </ul>
                </li>

                <li><strong>Recurrent UTI pattern:</strong> check organism history (relapse vs reinfection), triggers (sex/contraception), post‑coital symptoms, vaginal symptoms, and any urinary symptoms between infections.</li>

                <li><strong>Tests:</strong>
                  <ul>
                    <li>Urine dip may support diagnosis but do <strong>MSU for culture</strong> before antibiotics in suspected pyelonephritis (NICE NG111).</li>
                    <li>If recurrent UTI: send MSU during symptomatic episodes (ideally before antibiotics) to confirm infection/organism.</li>
                    <li>If unwell / red flags: record observations; consider bloods (FBC, U&amp;E/creatinine ± CRP) if this does not delay urgent referral (local process).</li>
                  </ul>
                </li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li><strong>If suspected pyelonephritis and stable for community treatment:</strong>
                  <ul>
                    <li>Send MSU for culture <strong>before</strong> antibiotics (NICE NG111).</li>
                    <li>Start oral antibiotics per <strong>local antimicrobial guidance</strong>.</li>
                    <li><strong>Safety‑net:</strong> symptoms should start improving within <strong>48 hours</strong>; seek help sooner if worsening or systemically unwell (NICE NG111).</li>
                  </ul>
                </li>

                <li><strong>Recurrent UTI prevention (overview):</strong>
                  <ul>
                    <li>Start with behavioural/self‑care measures; consider vaginal oestrogen in peri/post‑menopause if appropriate (NICE NG112).</li>
                    <li>If needed: targeted single‑dose prophylaxis for identifiable triggers or methenamine hippurate / daily antibiotic prophylaxis per NG112 (often needs shared decision making and sometimes specialist advice).</li>
                  </ul>
                </li>
              </ul>

              <h4>Who to refer</h4>
              <p class="small">Use the correct urgency and the correct local route. Do not delay acute referral for extra tests.</p>

              <h4>Same‑day assessment (ED / acute pathway / SDEC)</h4>
              <ul>
                <li>Suspected <strong>acute pyelonephritis</strong> with any red flags:</li>
                <li>
                  <ul>
                    <li>symptoms/signs of serious illness (e.g. sepsis) — <strong>refer to hospital</strong> (NICE NG111)</li>
                    <li>significant dehydration or unable to take oral fluids/medicines (NICE NG111)</li>
                    <li>pregnancy (NICE NG111)</li>
                    <li>higher risk of complications (structural/functional abnormality, diabetes, immunosuppression) with systemic symptoms (NICE NG111)</li>
                    <li>concern for obstruction/AKI/single kidney/transplant</li>
                  </ul>
                </li>
                <li><strong>Route (draft):</strong> ED / SDEC / acute medical assessment (confirm local route).</li>
              </ul>

              <h4>Urology / specialist advice (recurrent UTI workup)</h4>
              <ul>
                <li><strong>Refer / seek specialist advice</strong> for recurrent UTI in (NICE NG112):</li>
                <li>
                  <ul>
                    <li>men (male GU system) ≥16</li>
                    <li>recurrent <strong>upper</strong> UTI (pyelonephritis)</li>
                    <li>recurrent lower UTI when the underlying cause is unknown</li>
                    <li>pregnancy</li>
                    <li>after gender reassignment surgery with structural alteration of the urethra</li>
                  </ul>
                </li>
                <li>Include: MSU culture history (organisms/resistance), antibiotic courses, triggers, any imaging, and relevant comorbidities.</li>
              </ul>

              <h4>Cancer safety‑net branch (older adults)</h4>
              <ul>
                <li>Age <strong>60+</strong> with recurrent/persistent <strong>unexplained</strong> UTI → <strong>consider non‑urgent referral</strong> for bladder cancer (NICE NG12).</li>
                <li>If visible haematuria triggers are present, follow the haematuria pathway (separate DGRefHelp page).</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>Uncomplicated lower UTI responding to treatment, without red flags or concerning pattern.</li>
                <li>Recurrent UTI with an established prevention plan and good response (review in primary care; re-refer if pattern changes).</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm the D&amp;G acute route for suspected pyelonephritis needing same‑day assessment: <strong>ED</strong> vs <strong>SDEC/ambulatory</strong> vs <strong>on‑call medicine/urology</strong>.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm local criteria for <strong>complicated UTI</strong> that should be discussed with urology (stones/obstruction/catheter/post‑procedure etc.).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether any baseline bloods should be done <strong>before urgent referral</strong> vs leaving tests to the acute pathway.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm SCI Gateway destination/service names for <strong>urology</strong> (recurrent UTI workup) and any local <strong>urology cancer</strong> routes.</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑12)</h3>
              <ol>
                <li>NICE NG111: Pyelonephritis (acute): antimicrobial prescribing — recommendations (referral criteria; reassess if not improving within 48h; MSU before antibiotics). <a href="https://www.nice.org.uk/guidance/ng111/chapter/recommendations">nice.org.uk</a></li>
                <li>NICE NG112: Urinary tract infection (recurrent): antimicrobial prescribing — recommendations (who to refer/seek specialist advice; prevention options incl. vaginal oestrogen and methenamine hippurate). <a href="https://www.nice.org.uk/guidance/ng112/chapter/recommendations">nice.org.uk</a></li>
                <li>NICE NG12: Suspected cancer: recognition and referral — urological cancers section (consider non‑urgent referral for bladder cancer in age 60+ with recurrent/persistent unexplained UTI). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer#urological-cancers">nice.org.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
